- Home
- ITRM vs RADX Comparison
ITRM vs RADX Comparison
Compare ITRM & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- RADX
- Stock Information
- Founded
- ITRM 2015
- RADX 2021
- Country
- ITRM Ireland
- RADX Australia
- Employees
- ITRM N/A
- RADX N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- ITRM Health Care
- RADX
- Exchange
- ITRM Nasdaq
- RADX NYSE
- Market Cap
- ITRM 40.0M
- RADX 32.5M
- IPO Year
- ITRM 2018
- RADX N/A
- Fundamental
- Price
- ITRM $1.01
- RADX $4.70
- Analyst Decision
- ITRM Strong Buy
- RADX Strong Buy
- Analyst Count
- ITRM 2
- RADX 2
- Target Price
- ITRM $7.00
- RADX $13.50
- AVG Volume (30 Days)
- ITRM 481.0K
- RADX 21.2K
- Earning Date
- ITRM 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- ITRM N/A
- RADX N/A
- EPS Growth
- ITRM N/A
- RADX N/A
- EPS
- ITRM N/A
- RADX N/A
- Revenue
- ITRM N/A
- RADX $204,609.00
- Revenue This Year
- ITRM N/A
- RADX N/A
- Revenue Next Year
- ITRM $270.19
- RADX N/A
- P/E Ratio
- ITRM N/A
- RADX N/A
- Revenue Growth
- ITRM N/A
- RADX N/A
- 52 Week Low
- ITRM $0.81
- RADX $3.50
- 52 Week High
- ITRM $3.02
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- ITRM 51.14
- RADX N/A
- Support Level
- ITRM $0.93
- RADX N/A
- Resistance Level
- ITRM $1.06
- RADX N/A
- Average True Range (ATR)
- ITRM 0.05
- RADX 0.00
- MACD
- ITRM 0.01
- RADX 0.00
- Stochastic Oscillator
- ITRM 34.78
- RADX 0.00
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.